• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Knowledge, Attitude and Practice about a Newer Class of Antidiabetic Drug (Glucagon-like peptide-1 receptor agonist) Among the Health Care Professionals of Qassim University, Saudi Arabia
  • VIEWS 1919
  • PDF 620

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v20i4.MS21083

Year: 2021, Volume: 20, Issue: 4, Pages: 58-66

Original Article

Knowledge, Attitude and Practice about a Newer Class of Antidiabetic Drug (Glucagon-like peptide-1 receptor agonist) Among the Health Care Professionals of Qassim University, Saudi Arabia

Alwaleed Yousef Aldhobaib 1, Syed Imam Rabbani​ ✉ 2, Mugahid A Mobark 3

1 Pharm D Graduate, College of Pharmacy, Qassim University, Saudi Arabia
2 Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Saudi Arabia
3 Department of Pharmacy Practice, College of Pharmacy, Qassim University, Saudi Arabia
 
✉ Corresponding author: Syed Imam Rabbani
 
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a newer class of drugs used in the treatment of adult type-2 diabetes mellitus. The use of the drugs needs appropriate methods of administration including precautions and carry some potential risks such as pancreatitis and thyroid cell neoplasia. In this cross-sectional study, a pre-validated questionnaire with fixed-answers was used to assess the medical practitioner’s response towards recently approved drugs. Their replies were recorded in an excel sheet. The data was subjected to statistical analysis using one-way ANOVA and post-hoc tests to determine the significant value. p<0.05 was used to indicate the significance of the results. The data from the study indicated that 107 health care professionals such as physicians, nurses and pharmacists with differences in age, gender, nationality, qualification and experience took part in the survey. The overall correct response to the questions of knowledge domain was found to be 73.5%, attitude – 78.5% and practice – 80.3%. However, some critical information about the method of administration, precautions and possible risks associated with the therapy is lacking among the participants. A significant variation (P<0.05) was found for some of the demographic variables such as profession, qualification and age of the participants. The finding from the study suggests that the medical professionals have good knowledge, better attitude and proper practice about the GLP-1RA that is being approved for the treatment of type-2 diabetes mellitus. However, some of the vital aspects of the medication need update. Continuing medical education programs could be one of the most suitable strategies suggested for enlightening the information on the recent additions to the therapy.

 

Keywords

Knowledge, Attitude, Practice, Medical professionals, Type­2 diabetes, GLP­1RA

References

  1. Dawish MAA, Robert AA, Braham R, Hayek AAA, Saeed AA, Ahmed RA, et al. Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature. Current Diabetes Reviews. 2016;12(4):359–368. Available from: https://dx.doi.org/10.2174/1573399811666150724095130
  2. Tan SY, Wong JLM, Sim YJ, Wong SS, Elhassan SAM, Tan SH, et al. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(1):364–372. Available from: https://dx.doi.org/10.1016/j.dsx.2018.10.008
  4. Alzughbi T, Badedi M, Darraj H, Hummadi A, Jaddoh S, Solan Y, et al. <p>Diabetes-Related Distress and Depression in Saudis with Type 2 Diabetes</p>. Psychology Research and Behavior Management. 2020;Volume 13:453–458. Available from: https://dx.doi.org/10.2147/prbm.s255631
  5. Sami W, Alabdulwahhab KM, Hamid MRA, Alasbali TA, Alwadani FA, Ahmad MS. Dietary Attitude of Adults with Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Medicina. 2020;56(2):91. Available from: https://dx.doi.org/10.3390/medicina56020091
  6. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology. 2018;14(2):88–98. Available from: https://dx.doi.org/10.1038/nrendo.2017.151
  7. Kostial C, Manuwald U, Schulze J, Kugler J, Rothe U. Disease-Management-Programs in the Field of Diabetes Mellitus with Identification of the Best Practice in Europe: A Scoping Review. Hormone and Metabolic Research. 2020;52(03):149–157. Available from: https://dx.doi.org/10.1055/a-1111-8998
  8. Zhou Z, Sun B, Huang S, Jia W, Yu D. The tRNA-associated dysregulation in diabetes mellitus. Metabolism. 2019;94:9–17. Available from: https://dx.doi.org/10.1016/j.metabol.2019.01.017
  9. Mabilleau G, Gobron B, Bouvard B, Chappard D. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides. 2018;100:108–113. Available from: https://dx.doi.org/10.1016/j.peptides.2017.12.008
  10. Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet Diabetes & Endocrinology. 2019;7(10):776–785. Available from: https://dx.doi.org/10.1016/s2213-8587(19)30249-9
  11. Solanki J, Sheth N, Shah C, Mehta H. Knowledge, attitude, and practice of urban Gujarati type 2 diabetics: Prevalence and impact on disease control. Journal of Education and Health Promotion. 2017;6(1):35. Available from: https://dx.doi.org/10.4103/jehp.jehp_101_15
  12. Hazra A, Choudhury SD, Das S. Survey of knowledge-attitude-practice concerning insulin use in adult diabetic patients in eastern India. Indian Journal of Pharmacology. 2014;46(4):425. Available from: https://dx.doi.org/10.4103/0253-7613.135957
  13. Mehralian G, Yousefi N, Hashemian F, Maleksabet H, Knowledge. Attitude and Practice of Pharmacists regarding Dietary Supplements : A Community Pharmacy- based survey in Tehran. Iran J Pharm Res. 2014;13(4):1457–1465.
  15. Tejus A, Mathur AG, Vishnuprasad R, Singh A, Pradhan S. An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital. Medical Journal Armed Forces India. 2020;76(4):425–429. Available from: https://dx.doi.org/10.1016/j.mjafi.2019.08.004
  16. Al-Hanawi MK, Angawi K, Alshareef N, Qattan AMN, Helmy HZ, Abudawood Y, et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Frontiers in Public Health. 2020;8:217. Available from: https://dx.doi.org/10.3389/fpubh.2020.00217
  17. Gong J, Dong H, Xia QS, Huang Zy, Wang Dk, Zhao Y, et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infectious Diseases. 2020;20(1):963. Available from: https://dx.doi.org/10.1186/s12879-020-05681-5
  18. Wahab FA, Abdullah S, Abdullah JM, Jaafar H, Noor SS, Mohammad WM, et al. Updates on Knowledge, Attitude and Preventive Practices on Tuberculosis among Healthcare Workers. Malays J Med Sci. 2016;23(6):25–34.
  19. Adetunji O, Kalra S, Baruah M, Sahay R, Unnikrishnan A, Uppal S. Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future. Indian Journal of Endocrinology and Metabolism. 2016;20(2):254–267. Available from: https://dx.doi.org/10.4103/2230-8210.176351
  21. Zhang M, Zhou M, Tang F, Wang Y, Nie H, Zhang L, et al. Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China. Journal of Hospital Infection. 2020;105(2):183–187. Available from: https://dx.doi.org/10.1016/j.jhin.2020.04.012
  23. Farooqui M, Othman CN, Kanakal M. Knowledge, Attitudes, Practices (KAP) of Complementary & Alternative Medicine (CAM) Amongst Diploma Pharmacy Students in Malaysia. The Open Conference Proceedings Journal. 2013;4(1):165. Available from: https://dx.doi.org/10.2174/2210289201304010165
  24. Khan Y, Sarriff A, Khan A, Mallhi T. Knowledge, Attitude and Practice (KAP) Survey of Osteoporosis among Students of a Tertiary Institution in Malaysia. Tropical Journal of Pharmaceutical Research. 2014;13(1):155. Available from: https://dx.doi.org/10.4314/tjpr.v13i1.22
  25. Arbiol J, Orencio P, Romena N, Nomura H, Takahashi Y, Yabe M. Knowledge, Attitude and Practices towards Leptospirosis among Lakeshore Communities of Calamba and Los Baños, Laguna, Philippines. Agriculture. 2016;6(2):18. Available from: https://dx.doi.org/10.3390/agriculture6020018
  27. Kermode M, Holmes W, Langkham B, Thomas MS, Gifford S. HIV-related knowledge, attitudes and risk perception amongst nurses, doctors and other healthcare workers in rural India. Indian J Med Res. 2005;122(3):258–264.
  28. Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse Effects of GLP-1 Receptor Agonists. The Review of Diabetic Studies. 2014;11(3-4):202–230. Available from: https://dx.doi.org/10.1900/rds.2014.11.202
  29. Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. Diabetes, Obesity and Metabolism. 2017;19(4):524–536. Available from: https://dx.doi.org/10.1111/dom.12849
  30. VanNieuwenborg L, Goossens M, Lepeleire JD, Schoenmakers B. Continuing medical education for general practitioners: a practice format. Postgraduate Medical Journal. 2016;92(1086):217–222. Available from: https://dx.doi.org/10.1136/postgradmedj-2015-133662

Copyright

© 2021 Published by Krupanidhi Educational Trust. This is an open-access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/)

  • 18 February 2022

Year: 2021, Volume: 20, Issue: 4


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.